Understanding How Brain Stimulation Affects Mood and Behavior in Parkinson's Disease

In Parkinson’s disease (PD), treatments are often aimed at managing movement symptoms, but the condition also includes a variety of mood and behavior (neuropsychiatric) symptoms. These can fluctuate depending on medication: when PD medication is active (ON state), patients might experience feelings of well-being, energy, or even impulsive behavior. In contrast, when the medication is less effective or inactive (OFF state), patients often feel fatigue, sadness, and a lack of motivation. These emotional ups and downs add another layer of difficulty to managing the disease. A new tool, called the Neuropsychiatric Fluctuations Scale (NFS), was developed to capture and measure these emotional and mental changes directly in both the ON and OFF medication states. The NFS provides scores for two main categories: "NFS-plus" for symptoms that arise in the ON state, and "NFS-minus" for those in the OFF state. Together, these scores offer a clearer picture of a patient's overall mood and behavior changes. The study looked at whether deep brain stimulation (DBS)—a surgical treatment involving stimulation of the subthalamic nucleus (STN)—could help with these fluctuations in PD patients. Forty-five participants were evaluated using the NFS both before DBS surgery and again one year afterward. The findings were promising: DBS significantly reduced the intensity of these mood and behavior fluctuations, suggesting it may help improve mental stability in patients. Study Results The study analyzed the effects of DBS by comparing patients’ symptoms across two periods: before the DBS surgery and one year afterward. Here’s a breakdown of the main findings: Improved Mood Stability: The NFS revealed a significant reduction in mood and behavior fluctuation intensity after DBS, indicating a more stable emotional state across the day. Less Medication Needed: DBS allowed for about a 52% reduction in the amount of medication needed. This means patients might experience fewer side effects associated with PD medication. Better Quality of Life: Improvements were seen in areas that affect quality of life, including better attention and fewer mood issues. In summary, this study shows that STN-DBS could help reduce the intense mood and behavior changes that many PD patients experience. By reducing both the need for medication and the intensity of neuropsychiatric symptoms, DBS offers a valuable option for improving the overall management of Parkinson’s disease.